The FDA on Jan. 21 expanded its emergency use authorization for remdesivir to include the drug’s use in nonhospitalized patients with mild to moderate COVID-19 who have a high risk of their case becoming severe.
Read the full post on Becker's Hospital Review - Healthcare News
